ResearchMoz

Global and China Human Coagulation Factor VIII Industry 2013 Deep Research Report

QYResearch
Published Date » 2013-03-07
No. Of Pages » 150
  Summary  
   
 2013 Deep Research Report on Global and China Human Coagulation Factor Ⅷ Industry was professional and depth research report on Global and China Human Coagulation Factor Ⅷ industry. This report has firstly introduced Human Coagulation Factor Ⅷ definition classification industry chain etc related information.  
   
 Then introduced Human Coagulation Factor Ⅷ manufacturing technology and product specifications, And then summary statistics Global and China major Human Coagulation Factor Ⅷ manufacturers 2010-2016 Human Coagulation Factor Ⅷ capacity production supply demand shortage and Human Coagulation Factor Ⅷ selling price cost profit margin and production value, and also introduced International and China 18 manufacturers company basic...
Table of Contents

Chapter One Human Coagulation Factor Ⅷ (AHF) Industry Overview 1

1.1 Human Coagulation Factor Ⅷ Definition 1
1.2 Human Coagulation Factor Ⅷ Product Specifications 2
1.3 Human Coagulation Factor Ⅷ Price Analysis 2
1.4 Human Coagulation Factor Ⅷ Manufacturing Process 3
1.5 Human Coagulation Factor Ⅷ Cost Structure 5
1.6 Human Coagulation Factor Ⅷ Industry Overview 6

Chapter Two Recombinant Human Coagulation Factor Ⅷ (rFⅧ) Industry Overview 7

2.1 Recombinant Human Coagulation Factor Ⅷ Definition 7
2.2 Recombinant Human Coagulation Factor Ⅷ Product Specifications 8
2.3 Recombinant Human Coagulation Factor Ⅷ Price Analysis 8
2.4 Recombinant Human Coagulation Factor Ⅷ Manufacturing Process 9
2.5 Recombinant Human Coagulation Factor Ⅷ Cost Structure 10
2.6 Recombinant Human Coagulation Factor Ⅷ Industry Overview 11

Chapter Three Human Coagulation Factor Ⅷ Industry Chain Analysis 12

3.1 Raw Materials Market Analysis 12
3.1.1 Plasma Volume Analysis 12
3.2 Hemophilia Patients Analysis 13
3.3 Raw Materials-Human Coagulation Factor Ⅷ -Hemophilia Patients Industry Chain Analysis 15

Chapter Four Human Coagulation Factor Ⅷ Production Supply Sales Demand Market

Status and Forecast 17
4.1 Global Human Coagulation Factor Ⅷ Capacity Production Overview 17
4.2 China Human Coagulation Factor Ⅷ Capacity Production Overview 28
4.3 Europe US China Japan Korea Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production and Market Share 31
4.4 Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Production and Market Share 33
4.5 Global and China Key Manufacturers Human Coagulation Factor Ⅷ Capacity Utilization Rate 35
4.6 China Human Coagulation Factor Ⅷ Capacity Production and Its Global Proportion 37
4.7 Global and China Human Coagulation Factor Ⅷ Demand Overview 38
4.8 Global and China Human Coagulation Factor Ⅷ Supply Demand Shortage 40
4.9 Global and China Human Coagulation Factor Ⅷ Cost Price Production Value Gross Margin 42
4.10 China Human Coagulation Factor Ⅷ Import Export Consumption 43

Chapter Five Human Coagulation Factor Ⅷ Key Manufacturers Research 44

5.1 Baxter (USA) 44
5.2 BAYER (Germany) 53
5.3 CSL Behring (USA) 57
5.4 PFIZER (USA) 71
5.5 Grifols (Spain) 75
5.6 Octapharma (Switzerland) 80
5.7 GreenCross (Korea) 84
5.8 LFB (France) 93
5.9 BPL (UK) 97
5.10 Biotest (Germany) 100
5.11 Kedrion (Italy) 104
5.12 Intersero(Germany) 107
5.13 KAKETSUKEN (Japan) 109
5.14 MTPC (Japan) 112
5.15Shanghai RAAS Blood Products Co.,Ltd (Shanghai) 114
5.16 Hualan Biological Engineering Inc. (Henan) 121
5.17 Greencross(China) (Anhui) 126
5.18 Shandong Taibang Biological (Shandong) 129

Chapter Six Human Coagulation Factor Ⅷ New Project Investment Feasibility Analysis 133

6.1 Recombinant Human Coagulation Factor Ⅷ Project SWOT Analysis 133
6.2 200K Bottle/Year Recombinant Human Coagulation Factor Ⅷ (Type:200IU) New Project Investment Feasibility Analysis 134
6.2.1 Project Name 134
6.2.2 Project Products and Scale 134
6.2.3 Project Key Buildings 135
6.2.4 Project Schedule 135
6.2.5 Project Investments 135
6.2.6 Project Feasibility and Investment Return Analysis 136

Chapter Seven Human Coagulation Factor Ⅷ Industry Research Conclusions 136

List of Tables

Tables and Figures

Figure Human Coagulation Factor Ⅷ Product Picture (China Local) 1
Figure Human Coagulation Factor Ⅷ Product Picture (Import) 2
Table Human Coagulation Factor Ⅷ Product Specifications List 2
Table 2010-2016 Global Human Coagulation Factor Ⅷ (FⅧ) Price ($/IU) List 2
Table 2010-2016 China Human Coagulation Factor Ⅷ (FⅧ) Price ($/IU) List 3
Figure Human Coagulation Factor Ⅷ Manufacturing Process Flow 3
Table 2010-2016 Global Human Coagulation Factor Ⅷ (FⅧ) Price Cost Gross ($/IU) Gross Margin List 5
Table 2010-2016 China Human Coagulation Factor Ⅷ (FⅧ) Price Cost Gross ($/IU) Gross Margin List 5
Table 2012 Global and China Human Coagulation Factor Ⅷ Cost Structure ($/IU) 5
Figure Recombinant Human Coagulation Factor Ⅷ Product Picture 7
Table Recombinant Human Coagulation Factor Ⅷ Product Specifications List 8
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Price ($/IU) List 8
Table 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Price ($/IU) List 8
Figure Recombinant Human Coagulation Factor Ⅷ Manufacturing Process Flow 9
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Price Cost Gross ($/IU) Gross Margin List 10
Table 2012 China Recombinant Human Coagulation Factor Ⅷ Cost Structure ($/IU) 11
Table 2010-2016 Global Blood Products Annual Plasma Volume (Ton) List 12
Table 2010-2016 China Blood Products Annual Plasma Volume (Ton) List 12
Table 2010-2016 Global Blood Products Plasma Costs (10K RMB/Ton) List 12
Table 2010-2016 China Blood Products Plasma Costs (10K RMB/Ton) List 12
Table 2010-2016 Global and China Hemophilia A Patients (10K People) List 13
Table 2010-2016 Global and China Hemophilia A Patients Human Coagulation Factor Ⅷ Demand (10000IU) List 14
Table China Human Coagulation Factor Ⅷ Health Care Coverage List 14
Figure Raw Materials-Human Coagulation Factor Ⅷ-Hemophilia Patients Industry Chain Structure 15
Table Global Human Coagulation Factor Ⅷ Manufacturers and Product Price ($/IU) List 15
Table 2010-2016 Global 18 Manufacturers Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity and Total Capacity (10000IU) List 17
Table 2010-2016 Global 18 Manufacturers Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Market Share List 18
Table 2010-2016 Global 18 Manufacturers Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production and Total Production (10000IU) List 18
Table 2010-2016 Global 18 Manufacturers Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production Market Share List 19
Table 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 20
Figure 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 20
Table 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Utilization Rate List 21
Table 2010-2016 Global 16 Manufacturers Human Coagulation Factor Ⅷ Capacity and Total Capacity (10000IU) List 21
Table 2010-2016 Global 16 Manufacturers Human Coagulation Factor Ⅷ Capacity Market Share List 22
Table 2010-2016 Global 16 Manufacturers Human Coagulation Factor Ⅷ Production and Total Production (10000IU) List 22
Table 2010-2016 Global 16 Manufacturers Human Coagulation Factor Ⅷ Production Market Share List 23
Table 2010-2016 Global Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 23
Figure 2010-2016 Global Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 24
Table 2010-2016 Global Human Coagulation Factor Ⅷ Capacity Utilization Rate List 24
Table 2010-2016 Global 5 Manufacturers Recombinant Human Coagulation Factor Ⅷ Capacity and Total Capacity (10000IU) List 25
Table 2010-2016 Global 5 Manufacturers Recombinant Human Coagulation Factor Ⅷ Capacity Market Share List 25
Table 2010-2016 Global 5 Manufacturers Recombinant Human Coagulation Factor Ⅷ Production and Total Production (10000IU) List 25
Table 2010-2016 Global 5 Manufacturers Recombinant Human Coagulation Factor Ⅷ Production Market Share List 26
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 26
Figure 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 27
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Capacity Utilization Rate List 27
Table 2010-2016 China 4 Manufacturers Human Coagulation Factor Ⅷ Capacity and Total Capacity (10000IU) List 28
Table 2010-2016 China 4 Manufacturers Human Coagulation Factor Ⅷ Capacity Market Share List 28
Table 2010-2016 China 4 Manufacturers Human Coagulation Factor Ⅷ Production and Total Production (10000IU) List 28
Table 2010-2016 China 4 Manufacturers Human Coagulation Factor Ⅷ Production Market Share List 29
Table 2010-2016 China Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 29
Figure 2010-2016 China Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 29
Table 2010-2016 China Human Coagulation Factor Ⅷ Capacity Utilization Rate List 30
Table 2010-2016 China Key Manufacturers Recombinant Human Coagulation Factor Ⅷ Sales and Total Sales (10000IU) List 30
Table 2010-2016 China Key Manufacturers Recombinant Human Coagulation Factor Ⅷ Production Market Share List 30
Figure 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Sales (10000IU) and Growth Rate 31
Table 2010-2016Korea Japan China Europe United States etc Regions Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity (10000IU) List 31
Table 2010-2016Korea Japan China Europe United States etc Regions Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Market Share List 32
Table 2010-2016Korea Japan China Europe United States etc Regions Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production (10000IU) List 32
Table 2010-2016Korea Japan China Europe United States etc Regions Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production Market Share List 32
Table 2010-2016 Global Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Capacity (10000IU) List 33
Table 2010-2016 Global Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Capacity Market Share List 33
Table 2010-2016 Global Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Production (10000IU) List 33
Table 2010-2016 Global Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Production Market Share List 34
Table 2010-2016 China Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Capacity (10000IU) List 34
Table 2010-2016 China Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Capacity Market Share List 34
Table 2010-2016 China Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ production (10000IU) List 34
Table 2010-2016 China Human Coagulation Factor Ⅷ  Recombinant Human Coagulation Factor Ⅷ Production Market Share List 35
Table 2010-2016 Global and China 18 Manufacturers Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Utilization Rate List 35
Table 2010-2016 Global and China 16 Manufacturers Human Coagulation Factor Ⅷ Capacity Utilization Rate List 36
Table 2010-2016 Global and China 5 Manufacturers Recombinant Human Coagulation Factor Ⅷ Capacity Utilization Rate List 36
Table 2010-2016 China Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity (10000IU) and Its Global Proportion 37
Table 2010-2016 China Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production (10000IU) and Its Global Proportion 37
Table 2010-2016 China Human Coagulation Factor Ⅷ Capacity (10000IU) and Its Global Proportion 37
Table 2010-2016 China Human Coagulation Factor Ⅷ Production (10000IU) and Its Global Proportion 37
Table 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Sales (10000IU) and Its Global Proportion 38
Table 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Demand (10000IU) List 38
Table 2010-2016 Global Human Coagulation Factor Ⅷ Demand (10000IU) List 38
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Demand (10000IU) List 39
Table 2010-2016 China Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Demand (10000IU) List 39
Table 2010-2016 China Human Coagulation Factor Ⅷ Demand (10000IU) List 39
Table 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Demand (10000IU) List 39
Table China and Developed Countries Average Human Coagulation Factor Ⅷ Consumption Comparison 40
Table 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 40
Table 2010-2016 Global Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 40
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 40
Table 2010-2016 China Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 41
Table 2010-2016 China Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 41
Table 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Supply Demand Shortage (10000IU) List 41
Table 2010-2016 Global Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Production (10000IU) Price Cost Gross ($/IU) Production Value(10000$) and Gross Margin List 42
Table 2010-2016 Global Human Coagulation Factor Ⅷ Production (10000IU) Price Cost Gross ($/IU) Production Value(10000$) and Gross Margin List 42
Table 2010-2016 Global Recombinant Human Coagulation Factor Ⅷ Production (10000IU) Price Cost Gross ($/IU) Production Value(10000$) and Gross Margin List 42
Table 2010-2016 China Human Coagulation Factor Ⅷ Production (10000IU) Price Cost Gross ($/IU) Production Value(10000$) and Gross Margin List 43
Table 2010-2016 China Human Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Import Export Consumption (10000IU) List 43
Table 2010-2016 China Recombinant Human Coagulation Factor Ⅷ Import Export Consumption (10000IU) List 43
Table 2010-2016 China Human Coagulation Factor Ⅷ Import Export Consumption (10000IU) List 44
Table Baxter Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 44
Figure Baxter Human Coagulation Factor Ⅷ Product Hemofil M AHF 48
Figure Baxter Recombinant Human Coagulation Factor Ⅷ Product ADVATE 48
Figure Baxter Recombinant Human Coagulation Factor Ⅷ Product Recombinate (recombinant) 49
Figure Baxter Recombinant Human Coagulation Factor Ⅷ Product Immunate 49
Table Baxter Recombinant Human Coagulation Factor Ⅷ Product Specifications List 50
Table 2010-2016 Baxter Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 50
Figure 2010-2016 Baxter Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 51
Table 2010-2016 Baxter Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 51
Figure 2010-2016 Baxter Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 52
Table 2010-2016 BaxterHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 52
Figure 2010-2016 BaxterHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 53
Table BAYER Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 53
Figure BAYER Recombinant Human Coagulation Factor Ⅷ Product Kogenate FS 55
Table BAYER Recombinant Human Coagulation Factor Ⅷ Product Specifications List 55
Table 2010-2016 BAYER Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 56
Figure 2010-2016 BAYER Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 56
Table CSL Behring Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 57
Figure CSL Behring Human Coagulation Factor Ⅷ Product Humate-P® and Haemate® P 65
Figure CSL Behring Human Coagulation Factor Ⅷ Product Beriate® P 66
Figure CSL Behring Human Coagulation Factor Ⅷ Product Monoclate P 66
Figure CSL Bioplasma Human Coagulation Factor Ⅷ Product BIOSTATE 67
Figure CSL Behring Recombinant Human Coagulation Factor Ⅷ Product Helixate® FS and Helixate® NexGen 68
Table CSL Behring Human Coagulation Factor Ⅷ Product Specifications List 68
Table CSL Behring Recombinant Human Coagulation Factor Ⅷ Product Specifications List 68
Table 2010-2016 CSL Behring Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 69
Figure 2010-2016 CSL Behring Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 69
Table 2010-2016 CSL Behring Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 70
Figure 2010-2016 CSL Behring Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 70
Table 2010-2016 CSL BehringHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 70
Figure 2010-2016 CSL BehringHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 71
Table PFIZER Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 71
Figure PFIZER Recombinant Human Coagulation Factor Ⅷ Product ReFacto 73
Figure PFIZER Recombinant Human Coagulation Factor Ⅷ Product Xyntha 74
Table PFIZER Recombinant Human Coagulation Factor Ⅷ Product Specifications List 74
Table 2010-2016 PFIZER Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 74
Figure 2010-2016 PFIZER Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 75
Table Grifols Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 75
Figure GrifolsHuman Coagulation Factor Ⅷ Product Alphanate 77
Figure GrifolsHuman Coagulation Factor Ⅷ Product Fanhdi 78
Figure GrifolsHuman Coagulation Factor Ⅷ Product Koate-DVI (human) 78
Table GrifolsHuman Coagulation Factor Ⅷ Product Specifications List 79
Table 2010-2016 Grifols Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 79
Figure 2010-2016 Grifols Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 80
Table Octapharma Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 80
Figure OctapharmaHuman Coagulation Factor Ⅷ Product Wilate 82
Figure OctapharmaHuman Coagulation Factor Ⅷ Product Octanate 83
Table OctapharmaHuman Coagulation Factor Ⅷ Product Specifications List 83
Table 2010-2016 Octapharma Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 83
Figure 2010-2016 Octapharma Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 84
Table GreenCrossCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 84
Figure GreenCrossHuman Coagulation Factor Ⅷ Product GreenEight 87
Figure GreenCrossHuman Coagulation Factor Ⅷ Product GreenMono 87
Figure GreenCrossRecombinant Human Coagulation Factor Ⅷ Product GreenGene 88
Figure GreenCross Recombinant Human Coagulation Factor Ⅷ Product GreenGeneF 88
Table GreenCrossHuman Coagulation Factor Ⅷ Product Specifications List 89
Table GreenCross Recombinant Human Coagulation Factor Ⅷ Product Specifications List 89
Table 2010-2016 GreenCross Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 90
Figure 2010-2016 GreenCross Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 90
Table 2010-2016 GreenCrossRecombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 91
Figure 2010-2016 GreenCross Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 91
Table 2010-2016 GreenCrossHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 91
Figure 2010-2016 GreenCrossHuman Coagulation Factor Ⅷ +Recombinant Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 92
Table LFBCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 93
Figure LFB Human Coagulation Factor Ⅷ Product FACTANE 95
Table LFBHuman Coagulation Factor Ⅷ Product Specifications List 96
Table 2010-2016 LFB Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 96
Figure 2010-2016 LFBHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 96
Table Bio Products LaboratoryCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 97
Figure Bio Products Laboratory Human Coagulation Factor Ⅷ Product Optivate 98
Figure Bio Products Laboratory Human Coagulation Factor Ⅷ Product 8 Y 99
Table Bio Products Laboratory Human Coagulation Factor Ⅷ Product Specifications List 99
Table 2010-2016 Bio Products LaboratoryHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 100
Figure 2010-2016 Bio Products Laboratory Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 100
Table Biotest Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 101
Figure Biotest Human Coagulation Factor Ⅷ Product Haemoctin SDH 102
Table BiotestHuman Coagulation Factor Ⅷ Product Specifications List 103
Table 2010-2016 BiotestHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 103
Figure 2010-2016 BiotestHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 103
Table Kedrion Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 104
Figure Kedrion Human Coagulation Factor Ⅷ Product Emoclot D.I. 106
Table KedrionHuman Coagulation Factor Ⅷ Product Specifications List 106
Table 2010-2016 KedrionHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 106
Figure 2010-2016 KedrionHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 107
Table InterseroCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 107
Table 2010-2016 InterseroHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 109
Figure 2010-2016 InterseroHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 109
Table KAKETSUKENCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 110
Table KAKETSUKENHuman Coagulation Factor Ⅷ Product Specifications List 111
Table 2010-2016 KAKETSUKENHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 111
Figure 2010-2016 KAKETSUKENHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 112
Table MTPCCompany Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 112
Table 2010-2016 MTPCHuman Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 113
Figure 2010-2016 MTPCHuman Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 114
Table Shanghai RAAS Blood Products Co.,Ltd Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 114
Figure Shanghai RAAS Blood Products Co.,Ltd Human Coagulation Factor Ⅷ Product 116
Table Shanghai RAAS Blood Products Co.,Ltd Human Coagulation Factor Ⅷ Product Specifications List 118
Table 2010-2016 Shanghai RAAS Blood Products Co.,Ltd Human Coagulation Factor Ⅷ Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 119
Figure 2010-2016 Shanghai RAAS Blood Products Co.,Ltd Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 120
Table Hualan Biological Engineering Inc. Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 121
Figure Hualan Biological Engineering Inc. Human Coagulation Factor Ⅷ Product 122
Table Hualan Biological Engineering Inc. Human Coagulation Factor Ⅷ Product Specifications List 124
Table 2010-2016 Hualan Biological Engineering Inc. Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 124
Figure 2010-2016 Hualan Biological Engineering Inc. Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 125
Table Greencross(China) Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 126
Figure Greencross(China) Human Coagulation Factor Ⅷ Product 128
Table Greencross(China) Human Coagulation Factor Ⅷ Product Specifications List 128
Table 2010-2016 Greencross(China) Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 128
Figure 2010-2016 Greencross(China) Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 129
Table Shandong Taibang Biological Company Information Table (Products Applications Market Position Capacity Expansion Plan Contacts Information etc 12 Items) 129
Figure Shandong Taibang Biological Human Coagulation Factor Ⅷ Product 131
Table Shandong Taibang Biological Human Coagulation Factor Ⅷ Product Specifications List 132
Table 2010-2016 Shandong Taibang Biological Human Coagulation Factor Capacity Production (10000IU) Price Cost Gross ($/IU) Production Value (10000$) Gross Margin List 132
Figure 2010-2016 Shandong Taibang Biological Human Coagulation Factor Ⅷ Capacity Production (10000IU) and Growth Rate 132
Table 2013 China Recombinant Human Coagulation Factor Ⅷ Newe Project SWOT Analysis List 133
Table 200K Bottle/Year Recombinant Human Coagulation Factor Ⅷ (Type:200IU) New Project Schedule List 135
Table 200K Bottle/Year Recombinant Human Coagulation Factor Ⅷ (Type:200IU) New Project Investments List 135
Table 200K Bottle/Year Recombinant Human Coagulation Factor Ⅷ (Type:200IU) New Project Investment Return Rate and Feasibility Analysis 136

List of Figures

Upcoming Reports:

Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and common. Classic migraine is characterized by sudden change in eye sight and experience partial blindness or double vision. On the...
Vein Pattern Recognition Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast, 2012 - 2018
By - Transparency Market Research
The wide acceptance of biometrics such as facial recognition, fingerprinting, iris recognition, and hand geometry have already stormed the global biometrics market. However, the new vein recognition biometrics technology, with its unique features, is expected to create its mark in the biometrics market. Of all the latest biometrics technologies, vein pattern recognition is one of the fastest growing new entrants in this market. The vein pattern recognition technology works on the principle of identification of the subcutaneous vein patterns in the hand. As the user places his or...
Green Solvent and Bio-Solvents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
A solvent is generally any liquid (could be solid or gas also), which has the capacity to dissolve a substance (solute) in it resulting in the formation of a solution. The solvent market has seen a rise in the last few years, which has caused high levels of toxic emission in the atmosphere. Traditional solvents emit VOC (volatile organic compounds) and are being increasingly used in paints, aerosol, and in other similar industries. With environmental regulations to lower the emissions of VOC and bio-solvents or green-solvents have seen a growth in the past few years. The...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Warren Buffet Helps Burger King with Tim Horton Deal
Aug 27, 2014  
Renowned investor Warren Buffet plans to finance Burger King Worldwide Inc.’s acquisition of Tim Hortons Inc., the Canadian coffee chain. Berkshire Hathaway Inc., Warren Buffet’s firm will invest through preferred shares, it is speculated. Nearly 25% of the deal’s financing would be handled by Berkshire. The precise aim for Warren Buffet’s participation is yet...
Anti-UAW Workers to Form Another Union at Volkswagen Plant
Aug 27, 2014  
Employees at the Chattanooga plant of Volkswagen AG are trying to form a union of company’s salaried and hourly workers, as a means to counter the United Auto Workers Local 42 union that was established last month.  The new union is expected to force Volkswagen in rethinking and holding another vote to determine which union is favored by hourly employees. UAV had earlier...
Fairchild Axing 15% of its Workforce with Multiple Plant Closures
Aug 27, 2014  
American semiconductor manufacturer Fairchild has said that it will be laying off nearly 15% of its global workforce following the closure of its facilities in Malaysia, Utah, and Korea. The company will cease the production of five-inch silicon from its plant in Bucheon, Korea. It will also scale down its capacity to produce six-inch wafers. The company will bring these closures into effect...
Ralph Laurens Polo Tech to be unveiled at US Open
Aug 26, 2014  
In a bid to revolutionize the way sportspersons train and compete, lifestyle brand Ralph Lauren has created the Polo Tech shirt, to be launched on the opening day of the US Open. The shirt has merged biometrics into active lifestyle clothing with the aim of increasing and improving personal fitness.  The smart apparel collection by Ralph Lauren has sensors knitted into the...
Shares of Digital Ally Surge Due to Rising Interest in wearable cameras
Aug 26, 2014  
Amid the heated topic of the fatal shooting of an unarmed teenager by a Police officer in Missouri, there is one company that has inadvertently benefitted from the case.  Digital Ally Inc., a company that manufactures wearable cameras, observed a surge of nearly 80% in its shares. Company’s shares rose to $14.25 on Monday as the shooting case fueled an added demand for the...